Gemina Laboratories Ltd.
GLABF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40,460 | $74,562 | $46,852 | $28,606 |
| - Cash | -$0 | $15 | $1 | $42 |
| + Debt | $174 | $244 | $1,274 | $1,457 |
| Enterprise Value | $40,634 | $74,790 | $48,125 | $30,021 |
| Revenue | $0 | $11 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$2 | $11 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$297 | -$692 | -$1,348 | -$792 |
| % Margin | – | -6,358.2% | – | – |
| Net Income | -$299 | -$761 | -$1,421 | -$864 |
| % Margin | – | -6,994.2% | – | – |
| EPS Diluted | -0.004 | -0.01 | -0.019 | -0.012 |
| % Growth | 62.5% | 46.4% | -64.4% | – |
| Operating Cash Flow | -$21 | $31 | -$36 | -$176 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$21 | $31 | -$36 | -$176 |